Page 117 - CIBER-BBN2016-ENG

Most relevant scientific articles
• Díez-Martínez R., García-Fernández E., Manzano M., Martínez A., Domenech M., Vallet-Regí M. et al. Auranofin-loaded nanoparticles as a new therapeutic tool to fight streptococcal infections. Scientific Reports. 2016;6.
• Izquierdo-Barba I., Colilla M., Vallet-Regí M. Zwitterionic ceramics for biomedical applications. Acta Biomaterialia. 2016.
• Rodríguez-Palomo A., Monopoli D., Afonso H., Izquierdo-Barba I., Vallet-Regí M. Surface zwitterionization of customized 3D Ti6Al4V scaffolds: A promising alternative to eradicate bone infection. Journal of Materials Chemistry B. 2016;4(24):4356-4365.
• Vila M., García A., Girotti A., Alonso M., Rodríguez-Cabello J.C., González-Vázquez A. et al. 3D silicon doped hydroxyapatite scaffolds decorated with Elastin-like Recombinamers for bone regenerative medicine. Acta Biomaterialia. 2016;45:349-356.
• Paris J.L., Torre P.D.L., Manzano M., Cabanas M.V., Flores A.I., Vallet-Regí M. Decidua-derived mesenchymal stem cells as carriers of mesoporous silica nanoparticles. In vitro and in vivo evaluation on mammary tumors. Acta Biomaterialia. 2016.
Highlights
The most important achievements during 2016 include; (i) the development, optimization of nanotechnological strategies to design multifunctional smart nanosystems for bone cancer, osteoporosis and infection diseases and (ii) the design, fabrication and implantation of 3D scaffolds based on bioceramics for bone tissue regeneration.
This year; Prof. Vallet-Regí has obtained an Advanced Grant from the European Research Council entitled “polyValent mEsopoRous nanosystem for bone DIseases” (VERDI). GIBI group has also developed
diverse research lines in the frame of different national and international research projects including MAT2015-64831-R, MAT2013-43299-R, MAT2016-75611-R AEI/FEDER, PI15/00978 y CTQ2015-72605-EXP y H2020-Mozart 685872. Moreover, GIBI group has participated in different Intramural Projects (COATREG-
3D, GOLIATH, SCAFFBONE, SPRING, MULTISCAFF, NanoPrevHIV)) and translational CIBER-ECO project (SMART4NB).
GIBI group is member of the Research Institute of “Hospital 12 de Octubre (i+12)” and European Networking for prevention and treatment of osteoporotic fractures (www.agening.net). GIBI group has also published 22 original research articles indexed in JCR, 1 PCT-patent, 3 book chapters, and 17 invited conferences in international research forums. GIBI group during 2016 has supervised 2 PhD Theses obtaining both the maximum qualification, being one of them awarded by RANF.GIBI group collaborates with many clinic institutions as Hospital Miguel Servet, Zaragoza, La Paz Hospital, Madrid, Alcalá de Henares University Hospital, Jimenez Diaz Foundation, Hospital del Mar Barcelona, University Hospital of Getafe, University Children’s Hospital Niño Jesus. Furthermore, Prof. María Vallet-Regí has coordinated the activity “Intelligent Materials. Are the new biomaterials science fiction?” within the framework of the European Night of Researchers. Finally, Prof. María Vallet-Register has received the Lilly Foundation Prize for the Distinguished Scientific Career in the specialty of Chemistry.
BBN
Research Groups 117